Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
NCT ID: NCT06543914
Last Updated: 2025-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2024-11-26
2029-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Atogepant is an approved drug for preventive treatment of migraine in adults. Approximately 1000 adult participants who are prescribed atogepant by their doctors will be enrolled in this study across the world.
Participants will receive atogepant oral tablets as prescribed per standard clinical practice and will be followed for 2 years.
There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atogepant
Participants will receive atogepant as prescribed by their physician in routine clinical practice.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescribed atogepant according to the relevant approved local label.
* For participants who initiate atogepant at the prescribing physician or treating health care provider (HCP) discretion as part of their routine clinical care, the decision to administer atogepant must be made prior to and independent of recruitment into the study.
* Willing and able to comply with the requirements of the study.
* Not on concomitant preventive medication for migraine or have been on a stable preventive medication for migraine for at least 3 months prior to enrollment in the study. If on a stable preventive medication, the prescribing physician or treating HCP and participant must confirm that there is no plan to change concomitant preventive medication during the first 12 weeks of the study.
Exclusion Criteria
* Contraindications to atogepant as per local labeling.
* Pregnant or planning to be pregnant or women of childbearing potential not using contraception.
* Enrolled in any interventional studies that may include investigational compounds for migraine, or non-AbbVie observational studies.
* In the opinion of the prescribing physician or treating HCP, the participant has a history or current evidence of any condition that might interfere with patient's ability to comply with the study requirements.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neurology and Neurodiagnostics of Alabama /ID# 267614
Hoover, Alabama, United States
Rehabilitation & Neurological Services /ID# 267612
Huntsville, Alabama, United States
Barrow Neurological Institute - Dignity Health St. Joseph's Hosp and Medical Ctr /ID# 267610
Phoenix, Arizona, United States
Kenneth Martinez MD, A Medical Corp /ID# 267834
Aliso Viejo, California, United States
Los Angeles Headache Center /ID# 267570
Los Angeles, California, United States
Alcanza Clinical Research, LLC /ID# 267838
Lake Mary, Florida, United States
Norton Cancer Institute - St. Matthews /ID# 267605
Louisville, Kentucky, United States
Dent Neurologic Institute - Amherst /ID# 267606
Amherst, New York, United States
Grace Forde /ID# 267596
North New Hyde Park, New York, United States
Thomas Jefferson University Hospital /ID# 267572
Philadelphia, Pennsylvania, United States
Inova Health Care System /ID# 267615
Falls Church, Virginia, United States
Neuroscience Group /ID# 267571
Neenah, Wisconsin, United States
Cliniques Universitaires UCL Saint-Luc /ID# 270545
Brussels, Brussels Capital, Belgium
Universitair Ziekenhuis Brussel /ID# 269799
Jette, Brussels Capital, Belgium
Chu Tivoli /ID# 271254
La Louvière, Hainaut, Belgium
Centre Hospitalier Régional de la Citadelle /ID# 270539
Liège, Liege, Belgium
Groupe Sante CHC - Clinique du MontLegia /ID# 270218
Liège, Liege, Belgium
OLV Ziekenhuis Aalst /ID# 270284
Aalst, Oost-Vlaanderen, Belgium
AZ Sint-Jan Brugge /ID# 270540
Bruges, West-Vlaanderen, Belgium
AZ Groeninge /ID# 272772
Kortrijk, West-Vlaanderen, Belgium
Calgary Headache Assessment and Management Program /ID# 270266
Calgary, Alberta, Canada
Burrard Health Center /ID# 270268
Vancouver, British Columbia, Canada
Dr. Renju Kuriakose Prof. Corp. /ID# 273178
Saint John, New Brunswick, Canada
Maritime Neurology /ID# 270270
Halifax, Nova Scotia, Canada
Centricity /ID# 271478
London, Ontario, Canada
London Health Sciences Centre - Victoria Hospital & Children's Hospital /ID# 270943
London, Ontario, Canada
Bayshore Neurology /ID# 270673
Ottawa, Ontario, Canada
Sunnybrook Health Sciences Centre /ID# 273207
Toronto, Ontario, Canada
Centre de Recherche St-Louis /ID# 270957
Lévis, Quebec, Canada
Genge Partners /ID# 270267
Montreal, Quebec, Canada
Universitaetsklinikum Heidelberg /ID# 278134
Heidelberg, Baden-Wurttemberg, Germany
Universitaetsklinikum Tuebingen /ID# 275762
Tübingen, Baden-Wurttemberg, Germany
Praxis fur Neurologie Dr. med. Martin Delf /ID# 275918
Hoppegarten, Brandenburg, Germany
Zentrum Für Klinische Forschung Dr. Irma Schöll /ID# 275642
Bad Homburg, Hesse, Germany
Evangelisches Krankenhaus Oldenburg /ID# 275823
Oldenburg, Lower Saxony, Germany
Universitaetsmedizin Greifswald /ID# 276678
Greifswald, Mecklenburg-Vorpommern, Germany
ZNS Siegen /ID# 275660
Siegen, North Rhine-Westphalia, Germany
Dres. Huhn-Doll/Siquet/Vocke /ID# 279583
Velbert, North Rhine-Westphalia, Germany
Universitaetsklinikum Carl Gustav Carus Dresden /ID# 275759
Dresden, Saxony, Germany
Schmerzklinik Kiel /ID# 275592
Kiel, Schleswig-Holstein, Germany
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 275760
Berlin, , Germany
Schmerzzentrum Berlin /ID# 275819
Berlin, , Germany
Neurologischen Facharztzentrum Berlin /ID# 275919
Berlin, , Germany
Städtisches Klinikum Brandenburg /ID# 275725
Brandenburg, , Germany
IRCCS Ospedale San Raffaele /ID# 273153
Milan, Milano, Italy
Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 275269
Naples, Napoli, Italy
Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 274651
Rome, Roma, Italy
Sapienza University of Rome /ID# 273506
Rome, Roma, Italy
Azienda Ospedaliero Universitaria delle Marche /ID# 273349
Ancona, , Italy
Policlinico di Bari Ospedale Giovanni XXIII /ID# 275336
Bari, , Italy
Azienda Ospedaliero-Universitaria Renato Dulbecco /ID# 272696
Catanzaro, , Italy
Fondazione Mondino Istituto Neurologico Nazionale a Carattere Scientifico IRCCS /ID# 273155
Pavia, , Italy
Azienda Sanitaria Universitaria Giuliano Isontina - Trieste /ID# 274413
Trieste, , Italy
Gelre Ziekenhuis /ID# 272429
Apeldoorn, Gelderland, Netherlands
Maxima Medisch Centrum, Locatie Veldhoven /ID# 270278
Veldhoven, North Brabant, Netherlands
Zaans Medisch Centrum /ID# 269603
Zaandam, North Holland, Netherlands
Isala, locatie Zwolle /ID# 269602
Zwolle, Overijssel, Netherlands
Maasstad Ziekenhuis /ID# 269601
Rotterdam, South Holland, Netherlands
Hodeverket /ID# 271383
Sandnes, Rogaland, Norway
Oslo Hodepinesenter AS /ID# 271384
Oslo, , Norway
Unidade Local de Saude do Alto Ave, EPE /ID# 274767
Guimarães, Braga District, Portugal
Hospital da Luz /ID# 267002
Lisbon, Lisbon District, Portugal
Unidade Local de Saude de Loures-Odivelas, EPE /ID# 274764
Loures, Lisbon District, Portugal
CUF Sintra Hospital /ID# 272394
Sintra, Lisbon District, Portugal
Campus Neurológico Sénior /ID# 272392
Torres Vedras, Lisbon District, Portugal
Hospital CUF Coimbra /ID# 272393
Coimbra, , Portugal
Hospital CUF Porto /ID# 272788
Porto, , Portugal
Hospital Regional Universitario de Malaga /ID# 268272
Málaga, Andalusia, Spain
Hospital Universitari de Bellvitge /ID# 268224
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario Severo Ochoa /ID# 268249
Leganés, Madrid, Spain
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 268246
Majadahonda, Madrid, Spain
Hospital Universitario Central de Asturias /ID# 276477
Oviedo, Principality of Asturias, Spain
Hospital Universitario Virgen Macarena /ID# 268244
Seville, Sevilla, Spain
Hospital Universitario Vall de Hebron /ID# 268222
Barcelona, , Spain
Hospital Universitario de La Princesa /ID# 268245
Madrid, , Spain
Hospital Universitario La Paz /ID# 268238
Madrid, , Spain
Hospital Alvaro Cunqueiro /ID# 268248
Pontevedra, , Spain
Hospital Universitario Virgen del Rocio /ID# 268223
Seville, , Spain
Hospital Clinico Universitario de Valladolid /ID# 268225
Valladolid, , Spain
Hospital Clinico Universitario Lozano Blesa /ID# 268243
Zaragoza, , Spain
Karolinska Universitetssjukhuset - Huddinge /ID# 265295
Huddinge, Stockholm County, Sweden
Neurology Clinic /ID# 266707
Stockholm, Stockholm County, Sweden
Skaneuro /ID# 265203
Lund, , Sweden
NeuroPraxis Birseck /ID# 266140
Reinach, Basel-Landschaft, Switzerland
ZURZACH Care /ID# 265697
Bad Zurzach, Canton of Aargau, Switzerland
CHUV, Centre hospitalier universitaire vaudois /ID# 266551
Lausanne, Canton of Vaud, Switzerland
Kopfwehzentrum Hirslanden Zuerich /ID# 265817
Zollikon, Canton of Zurich, Switzerland
Neurozentrum Bellevue /ID# 277666
Zurich, Canton of Zurich, Switzerland
University Hospital Zurich /ID# 276450
Zurich, Canton of Zurich, Switzerland
DYA Swiss Institut SA /ID# 266891
Lugano, Canton Ticino, Switzerland
EOC Ospedale Regionale Lugano /ID# 266887
Lugano, Canton Ticino, Switzerland
Hôpital De Sion /ID# 276360
Sion, Valais, Switzerland
Inselspital, Universitaetsspital Bern /ID# 265818
Bern, , Switzerland
Tri-Service General Hospital /ID# 272082
Taipei, , Taiwan
Linkou Chang Gung Memorial Hospital /ID# 272084
Taoyuan, , Taiwan
American Center of Neurology and Psychiatry /ID# 276429
Abu Dhabi, , United Arab Emirates
Hull Royal Infirmary /ID# 276819
Hull, East Riding Of Yorkshire, United Kingdom
Western General Hospital - NHS Lothian /ID# 277029
Edinburgh, Edinburgh, City of, United Kingdom
Guy's Hospital /ID# 276817
London, Greater London, United Kingdom
King'S College Hospital /ID# 276818
London, Greater London, United Kingdom
Cripps Health Centre /ID# 277474
Nottingham, Nottinghamshire, United Kingdom
University Hospitals North Midlands - Royal Stoke University Hospital /ID# 276821
Stoke-on-Trent, Staffordshire, United Kingdom
Leeds Teaching Hospitals NHS Trust /ID# 279417
Leeds, West Yorkshire, United Kingdom
Great Western Hospital /ID# 276693
Swindon, Wiltshire, United Kingdom
Worcestershire Royal Hospital /ID# 276902
Worcester, Worcestershire, United Kingdom
Ulster Hospital - South Eastern Health & Social Care Trust /ID# 276900
Belfast, , United Kingdom
University Hospital of Wales /ID# 276822
Cardiff, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Site Coordinator
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P24-880
Identifier Type: -
Identifier Source: org_study_id